Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dinoprostone adverse reaction |
Causative agent (attribute) |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to dinoprostone |
Causative agent (attribute) |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dinoprostone 10mg pessary (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dinoprostone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dinoprostone 5mg/0.5mL extra-amniotic solution+diluent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dinoprostone 400 microgram/mL vaginal gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dinoprostone 3 mg vaginal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral dinoprostone (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing dinoprostone in vaginal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone 10mg insert |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dinoprostone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Prostaglandin PGE2 measurement (procedure) |
Component |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cervical ripening with Prostaglandin E2 |
Direct substance |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cervical ripening with Prostaglandin E2 |
Direct substance |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to dinoprostone |
Causative agent (attribute) |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone 3 mg vaginal tablet |
Has basis of strength substance (attribute) |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone 3 mg vaginal tablet |
Has precise active ingredient |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 5 milligram/0.5 milliliter conventional release solution for infusion ampule |
Has precise active ingredient |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 5 milligram/0.5 milliliter conventional release solution for infusion ampule |
Has basis of strength substance (attribute) |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone 400 microgram/mL vaginal gel |
Has basis of strength substance (attribute) |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone 400 microgram/mL vaginal gel |
Has precise active ingredient |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug) |
Has precise active ingredient |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 750 microgram/0.75 milliliter conventional release solution for infusion ampule |
Has precise active ingredient |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 750 microgram/0.75 milliliter conventional release solution for infusion ampule |
Has basis of strength substance (attribute) |
False |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only dinoprostone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only dinoprostone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone only product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone 1 mg/mL solution for infusion |
Has precise active ingredient |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone 1 mg/mL solution for infusion |
Has basis of strength substance (attribute) |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone 10 mg prolonged-release vaginal pessary |
Has precise active ingredient |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone 10 mg prolonged-release vaginal pessary |
Has basis of strength substance (attribute) |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone 1 mg/mL solution for injection |
Has precise active ingredient |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone 1 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 1 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has precise active ingredient |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 1 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has precise active ingredient |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dinoprostone 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone 10 mg prolonged-release vaginal delivery system |
Has precise active ingredient |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dinoprostone 10 mg prolonged-release vaginal delivery system |
Has basis of strength substance (attribute) |
True |
Dinoprostone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |